title: Estrogen's dual nature? Studies highlight effects on breast cancer.
authors.forename: Renee
authors.initials: R
authors.lastname: Twombly
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D001943:Breast Neoplasms / Q000139:chemically induced* / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control*; D002273:Carcinogens / Q000037:antagonists & inhibitors; D002986:Clinical Trials as Topic; D004054:Diethylstilbestrol / Q000008:administration & dosage* / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004965:Estrogen Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004967:Estrogens / Q000009:adverse effects / Q000378:metabolism* / Q000627:therapeutic use*; D004968:Estrogens, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000139:chemically induced / Q000517:prevention & control; D017698:Postmenopause; D017697:Premenopause; D013629:Tamoxifen / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D018931:Antineoplastic Agents, Hormonal; D002273:Carcinogens; D004965:Estrogen Antagonists; D004967:Estrogens; D004968:Estrogens, Non-Steroidal; D013629:Tamoxifen; D004054:Diethylstilbestrol